Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of Korean adolescent girls
Open Access
- 18 March 2024
- journal article
- research article
- Published by Korean Society of Epidemiology in Epidemiology and Health
- Vol. 46, e2024040
Abstract
OBJECTIVES: The purpose of this study was to assess the effectiveness of human papillomavirus (HPV) vaccination administered to adolescent girls through Korea’s National Immunization Program.METHODS: This retrospective cohort study included patients who were 12-13 years old, whether vaccinated or unvaccinated, between July 2016 and December 2017. The incidence of genital warts (GWs) was monitored through 2021. Time-stratified hazard ratios (HRs) were estimated, adjusting for birth year, socioeconomic status, and the level of urbanization of the region, and were presented with 95% confidence intervals (CIs). Data were sourced from the Immunization Registry Integration System, linked with the National Health Information Database.RESULTS: The study included 332,062 adolescent girls, with an average follow-up period of approximately 4.6 years. Except for the first year, the HRs for the vaccinated group were lower than those for the unvaccinated group. The HRs for specific cut-off years were as follows: year 2, 0.62 (95% CI, 0.31 to 1.13); year 3, 0.58 (95% CI, 0.35 to 0.96); and year 4 and beyond, 0.39 (95% CI, 0.28 to 0.52).CONCLUSIONS: Our findings indicate that HPV vaccination was associated with a reduction in the risk of GWs among adolescent girls. Notably, this reduction became significant as the incidence of GWs increased with age.Keywords
This publication has 23 references indexed in Scilit:
- Human papillomavirus vaccines effectiveness to prevent genital warts: A population-based study using health system integrated databases, 2009–2017Vaccine, 2022
- Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and womenPreventive Medicine, 2020
- 2019 IUSTI‐Europe guideline for the management of anogenital wartsJournal of the European Academy of Dermatology and Venereology, 2020
- Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysisThe Lancet, 2019
- The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002–2015Vaccine, 2018
- Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world ExperienceClinical Infectious Diseases, 2016
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2015
- Changes in Incidence of Anogenital Warts Diagnoses After the Introduction of Human Papillomavirus Vaccination in Germany—An Ecologic StudySexually Transmitted Diseases, 2013
- Survival analysis: time-dependent effects and time-varying risk factorsKidney International, 2008
- Measuring Diagnoses: ICD Code AccuracyHealth Services Research, 2005